Home/Filings/4/0001209191-17-048673
4//SEC Filing

Dubensky Thomas W. 4

Accession 0001209191-17-048673

CIK 0001435049other

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 8:03 PM ET

Size

14.9 KB

Accession

0001209191-17-048673

Insider Transaction Report

Form 4
Period: 2017-08-10
Dubensky Thomas W.
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2017-08-10$11.43/sh40,912$467,66539,900 total
  • Sale

    Common Stock

    2017-08-11$11.17/sh9,088$101,53839,900 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-08-119,088126,328 total
    Exercise: $1.00Exp: 2024-07-30Common Stock (9,088 underlying)
  • Exercise/Conversion

    Common Stock

    2017-08-11$1.00/sh+9,088$9,08848,988 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-08-1040,912135,416 total
    Exercise: $1.00Exp: 2024-07-30Common Stock (40,912 underlying)
  • Exercise/Conversion

    Common Stock

    2017-08-10$1.00/sh+40,912$40,91280,812 total
Footnotes (4)
  • [F1]The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2017.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.10 to $12.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.10 to $11.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F4]The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of July 31, 2014.

Issuer

ADURO BIOTECH, INC.

CIK 0001435049

Entity typeother

Related Parties

1
  • filerCIK 0001635590

Filing Metadata

Form type
4
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 8:03 PM ET
Size
14.9 KB